Literature DB >> 1359782

Pulmonary infiltrates and skin pigmentation associated with sulfasalazine.

E C Gabazza1, O Taguchi, T Yamakami, M Machishi, H Ibata, S Suzuki, K Matsumoto, T Kitagawa, J Yamamoto.   

Abstract

A patient with ulcerative colitis developed skin pigmentation and diffuse pulmonary shadowing without respiratory symptomatology, while taking sulfasalazine. The clinical picture and radiological abnormalities disappeared spontaneously on discontinuation of the drug. Histopathological studies from specimens taken by transbronchial biopsy showed bronchiolitis obliterans with fibrosing alveolitis. Sulfasalazine-induced lung disorder is an extremely rare entity which must be considered in all ulcerative colitis patients while on sulfasalazine therapy, despite the absence of pulmonary symptomatology.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1359782

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  4 in total

Review 1.  Organising pneumonia.

Authors:  J F Cordier
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

Review 2.  Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.

Authors:  C P Rains; S Noble; D Faulds
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

3.  Bronchiolitis obliterans organizing pneumonia associated with sulfasalazine in a patient with rheumatoid arthritis.

Authors:  Bahar Ulubaş; Günşah Sahin; Caner Ozer; Ozlem Aydin; Eylem Ozgür; Demir Apaydin
Journal:  Clin Rheumatol       Date:  2004-02-24       Impact factor: 2.980

4.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Sebastian Majewski; Wojciech Piotrowski
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.